Learn more about the Registry
Alternatively, call the registry team toll-free at
1-866-609-1612
(hours of operation 8:30 AM - 5:00 PM EST Monday-Friday)
Are you pregnant and diagnosed with Non-Erosive Gastroesophageal Reflux Disease (Non-Erosive GERD), Erosive Esophagitis (Erosive GERD), or Helicobacter pylori (H. pylori) infection?
Have you taken VOQUEZNA® (vonoprazan) tablets for the treatment of Non-Erosive GERD, Erosive GERD or H. pylori infection, or VOQUEZNA® DUAL PAK® (vonoprazan tablets; amoxicillin capsules) or VOQUEZNA® TRIPLE PAK® (vonoprazan tablets; amoxicillin capsules; clarithromycin tablets) for the treatment of H. pylori infection, or taken other medications for the treatment of Non-Erosive GERD, Erosive GERD or H. pylori infection during your pregnancy?
Gastroesophageal conditions may have a significant impact on quality of life. Help future pregnant women, doctors, and researchers understand the safety of medications that treat these conditions.
Are you a healthcare provider who treats pregnant women with Non-Erosive GERD, Erosive GERD, or H. pylori infection?
Help us learn more about the safety profile of using VOQUEZNA, VOQUEZNA DUAL PAK or VOQUEZNA TRIPLE PAK, or other medications for the treatment of Non-Erosive GERD, Erosive GERD or H. pylori infection during pregnancy.
A pregnancy registry is a study that collects health information from women who take prescription medications while they are pregnant. Information is also collected on the newborn baby. This information is compared with women who have not or have taken other medications during pregnancy.
The goal of the VOQUEZNA Pregnancy Registry is to help healthcare providers, patients, and researchers better understand the safety of VOQUEZNA, VOQUEZNA DUAL PAK, and VOQUEZNA TRIPLE PAK, as well as other medications for the treatment of Non-Erosive GERD, Erosive GERD, or H. pylori infection during pregnancy. Pregnant women in the United States with Non-Erosive GERD, Erosive GERD, or H. pylori infection may be eligible to participate. The study gathers health information on pregnant women and their babies up to one year old, sourcing data from both the enrolled women and the healthcare providers involved in their care.
VOQUEZNA is not recommended during pregnancy or during breastfeeding or in women of childbearing potential not using effective contraception. It is important that you discuss the potential risks and benefits of taking VOQUEZNA or any other medication during pregnancy or during breastfeeding with your doctor.
Alternatively, call the registry team toll-free at
1-866-609-1612
(hours of operation 8:30 AM - 5:00 PM EST Monday-Friday)
IMPORTANT SAFETY INFORMATION
VOQUEZNA
Do not take VOQUEZNA if you:
Before taking VOQUEZNA, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
VOQUEZNA may affect how other medicines work, and other medicines may affect how VOQUEZNA works. Especially tell your healthcare provider if you take medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY).
What are the possible side effects of VOQUEZNA?
VOQUEZNA may cause serious side effects including:
The most common side effects of VOQUEZNA for treatment of Erosive Esophagitis and/or relief of heartburn related to gastroesophageal reflux disease include:
The most common side effects of VOQUEZNA when used with antibiotics for treatment of H. pylori infection include:
These are not all the possible side effects of VOQUEZNA. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects.
You are encouraged to report suspected adverse reactions by contacting Phathom Pharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see Patient Information and full Prescribing Information for VOQUEZNA.
IMPORTANT SAFETY INFORMATION
VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK
Do not take VOQUEZNA TRIPLE PAK if you:
Do not take VOQUEZNA DUAL PAK if you:
Before you take VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK, tell your healthcare provider about all of your medical conditions, including if you:
Additionally, do not take VOQUEZNA TRIPLE PAK if:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. There can be serious side effects when some are used in combination with this product. Serious adverse reactions can occur with VOQUEZNA TRIPLE PAK due to drug interactions of clarithromycin with colchicine, some lipid lowering agents, some calcium channel blockers, and other drugs.
What are the possible side effects of VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK?
VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK can cause serious side effects including:
Additionally, VOQUEZNA TRIPLE PAK can cause:
The most common side effects may include:
These are not all of the possible side effects of VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK. Call your healthcare provider for medical advice about side effects.
General information about the safe and effective use of VOQUEZNA.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK for a condition for which it was not prescribed. Do not give VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK to other people, even if they have the same symptoms you have. It may harm them.
For more information, ask your healthcare provider or pharmacist.
You are encouraged to report suspected adverse reactions by contacting Phathom Pharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
If you have been prescribed VOQUEZNA TRIPLE PAK or VOQUEZNA DUAL PAK, please see full Prescribing Information for VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK.